Mikart's Nazar Elkarim discusses the importance of failing fast during early drug development, especially for pharma startups, and how Mikart's extensive formulation, method, and process development expertise and dedicated very-small-scale lab equipment allow drug developers to make go/no-go decisions with confidence.
.svg)
